Avidity Biosciences
RNA
#1835
Rank
ยฃ8.10 B
Marketcap
ยฃ53.77
Share price
0.13%
Change (1 day)
86.02%
Change (1 year)

Avidity Biosciences (RNA) Fails to deliver data

Key failure to deliver metrics for Avidity Biosciences:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Avidity Biosciences (RNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Avidity Biosciences (RNA) - since 2020

Volume in USD (price x number of shares), data since 2020

Avidity Biosciences (RNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025ยฃ35.33 M119.26%
2024ยฃ16.11 M267.16%
2023ยฃ4.38 M-91.34%
2022ยฃ50.7 M162.44%
2021ยฃ19.31 M-77.68%
2020ยฃ86.53 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
PTC Therapeutics
PTCT
ยฃ3.49 Mยฃ32.41 M๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
N/Aยฃ0.01 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ2.3 Mยฃ22.38 M๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
ยฃ0.04 Mยฃ0.78 M๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
ยฃ0.6 Mยฃ1.39 M๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ24.63 Mยฃ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ72.01 Mยฃ0.40 B๐Ÿ‡ฌ๐Ÿ‡ง UK